Y. Ralph Chu, MD, welcomes Selina McGee, OD, FAAO, to discuss how the evaluation of presbyopia treatment options allows for more customized therapy for patients. The two explain how the presbyopia treatment landscape has evolved in recent years and how they talk to patients about all therapeutic options, including the recently FDA-approved Vuity (pilocarpine HCl ophthalmic solution 1.25%, Allergan). Dr. McGee says that, with several different therapeutic options, she can tailor treatment based on a comprehensive eye examination and consultation about a patient’s lifestyle goals.
Podden och tillhörande omslagsbild på den här sidan tillhör
Eyetube. Innehållet i podden är skapat av Eyetube och inte av,
eller tillsammans med, Poddtoppen.
